Active Ingredient(s):Tacrolimus FDA Approved: * December 8, 2000 Pharm Company: *ASTELLAS Category:Skin Care
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After allogeneic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given. The drug can also be sold as a topical medication in the treatment of T-cell-mediated diseases such as eczema and psoriasis. For example, it is prescribed for severe refractory uveitis after a bone marrow transplant, exacerbations of minimal change disease, Kimura's disea...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions